Financial Review: Oriental Rise (NASDAQ:ORIS) versus Medifast (NYSE:MED)

Oriental Rise (NASDAQ:ORIS) and Medifast (NYSE:MED) are both small-cap consumer staples companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, earnings, institutional ownership, risk, valuation, profitability and analyst recommendations.

Profitability

This table compares Oriental Rise and Medifast’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Oriental Rise	N/A	N/A	N/A
Medifast	-5.78%	-4.80%	-3.83%

Risk and Volatility

Oriental Rise has a beta of 1.54, meaning that its share price is 54% more volatile than the S&P 500. Comparatively, Medifast has a beta of 0.65, meaning that its share price is 35% less volatile than the S&P 500.

Earnings & Valuation

This table compares Oriental Rise and Medifast”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Oriental Rise	$12.22 million	0.04	$680,000.00	N/A	N/A
Medifast	$385.79 million	0.29	-$18.67 million	($1.83)	-5.42

Oriental Rise has higher earnings, but lower revenue than Medifast.

Insider and Institutional Ownership

95.5% of Medifast shares are held by institutional investors. 3.7% of Medifast shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Analyst Recommendations

This is a summary of current recommendations and price targets for Oriental Rise and Medifast, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Oriental Rise	1	0	0	0	1.00
Medifast	1	1	0	1	2.33

Medifast has a consensus price target of $12.00, indicating a potential upside of 20.96%. Given Medifast’s stronger consensus rating and higher probable upside, analysts plainly believe Medifast is more favorable than Oriental Rise.

Summary

Medifast beats Oriental Rise on 7 of the 12 factors compared between the two stocks.

About Oriental Rise

Oriental Rise Holdings Ltd. engages in the cultivation, processing, and sale of tea leaves and tea products. It operates through the Primarily-Processes Teas and Refined Teas segments. The company was founded by Chun Sun Wong, Wai Kwong Fong and Deming Zhou on January 25, 2019 and is headquartered in Ningde, China.

About Medifast

Medifast, Inc., through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names. The company markets its products through point-of-sale transactions, as well as through ecommerce platform. Medifast, Inc. was founded in 1980 and is headquartered in Baltimore, Maryland.